Skip to main content

Nicole Germino

Stock Analyst at Truist Financial

Total Price Targets
5
Stocks Covered
3
Sectors
Healthcare
Most Recent
Sep 25, 2024

Stocks Covered by Nicole Germino

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
CATXPerspective Therapeutics, Inc.$21.00$3.90+439.2%1Sep 25, 2024
INSMInsmed Incorporated$88.00$133.75-34.2%3Jul 1, 2024
SGMOSangamo Therapeutics, Inc.$19.00$0.13+14755.4%1Apr 5, 2022

Recent Activity

  • Sep 25, 2024— Set$21.00price target onCATX(Perspective Therapeutics, Inc.)
  • Jul 1, 2024— Set$88.00price target onINSM(Insmed Incorporated)
  • May 29, 2024— Set$68.00price target onINSM(Insmed Incorporated)
  • Apr 23, 2024— Set$48.00price target onINSM(Insmed Incorporated)
  • Apr 5, 2022— Set$19.00price target onSGMO(Sangamo Therapeutics, Inc.)

Frequently Asked Questions

Who is Nicole Germino?

Nicole Germino is a stock analyst at Truist Financial covering 3 stocks primarily in Healthcare. They have issued 5 price targets since Apr 5, 2022.

What stocks does Nicole Germino cover?

Nicole Germino currently covers 3 stocks, including INSM, CATX, SGMO.

What is Nicole Germino's latest price target?

Nicole Germino's most recent price target was $21.00 on CATX (Perspective Therapeutics, Inc.), set on Sep 25, 2024.

What is Nicole Germino's highest price target?

Nicole Germino's highest issued price target is $88.00 on INSM, set on Jul 1, 2024.

Coverage based on publicly published price targets. Not investment advice.